Disease



ALZHEIMER’S DISEASE


Alzheimer’s disease is an age-related brain disease often associated with profound cognitive decline. Recent research suggests that key aspects of the disease may be tightly intertwined with the body’s endocannabinoid system. In the near future, preventive measures for Alzheimer’s could foreseeably target parts of the endocannabinoid system and some treatments for Alzheimer’s could be cannabinoid-based.1



Historical Uses


In 1890, Sir John Russell Reynolds, MD, physician to Queen Victoria, published an account of using cannabis to treat senile dementia in the British medical journal The Lancet. Reynolds described using a Cannabis indica extract.


He wrote: “In senile insomnia, with wandering; where an elderly person probably with brain-softening, in the ‘delirium form’ (Durand-Fardel) is fidgety at night, goes to bed, gets up again, and fusses over his clothes and his drawers . . . but may be quite rational during the day, with its stimuli and real occupations. In this class of case I have found nothing comparable in utility to a moderate dose of Indian hemp-viz., one-quarter to one-third of a grain of the extract, given at bedtime. It has been absolutely successful for months, and indeed years, without any increase of the dose.”2 Reynolds’s account is a classic example of using cannabis to calm and mildly sedate a patient with Alzheimer’s-like dementia.


Description

Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

Jun 24, 2016 | Posted by in PHARMACY | Comments Off on Disease

Full access? Get Clinical Tree

Get Clinical Tree app for offline access